Literature DB >> 30574940

Comment on: Pars-plana fluid aspiration for positive vitreous cavity pressure in anterior segment surgeries.

Arjun Srirampur1, Anupama Kalwad2, Pasyanthi Balijepalli3, Kavya Reddy Katta2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30574940      PMCID: PMC6324136          DOI: 10.4103/ijo.IJO_723_18

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Sir, We read the interesting article “Pars plana fluid aspiration for vitreous cavity pressure in anterior segment surgeries” by Kuriakose et al. published in Issue 4 of the Indian Journal of Ophthalmology (IJO), 2018. The authors proposed a novel surgical technique to address a complex and vexing intraoperative complication commonly encountered in anterior segment surgeries.[1] The authors proposed this surgical technique for patients with shallow anterior chamber due to positive vitreous pressure, the causes of which could be poor akinesia, inadvertent pressure on the globe, proptosis, eyelid abnormalities, etc.[2] When these external causes are ruled out, infusion misdirection syndrome is another entity where there is misdirection of irrigating fluid into vitreous cavity that can occur due to excessive hydrodissection or during cortical aspiration.[3] Though the authors have ruled out external causes such as lid speculum issues, hand position and instrument position, one of the most important causes was missed, i.e., the type of local anesthesia and its adequacy. There were also no details regarding suspected infusion misdirection intraoperatively. Although it was mentioned that the aspiration was done before the surgery in patients where an aqueous misdirection was suspected, we are not sure if they intended that to be in cases with high possibility of aqueous misdirection intra/postoperatively as it happens post surgery and needs ultrasound biomicroscopy (UBM) for confirming the diagnosis.[4] Half of the patients included in the study were above the age of 60 years, in whom the possibility of vitreous degeneration was high and aspiration of misdirected fluid alone was debatable. When we consider the safety issues of this technique, the authors suggested to continue aspiration till the syringe exits out of the eye, which could possibly cause damage to the pars plana. Incidence of complications with this procedure such as vitreous traction has been compared to that of intravitreal injections, but it may not hold true as fluid is aspirated with this technique compared to injection of fluid in the latter. In addition, an incorrect positioning of the needle increases the risk for lens touch and retinal breaks in addition to risk of damage to the pars plana. Currently available advancements including suture-less vitrectomy with 27 or 25-gauge needle would be safer alternatives.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Acute intraoperative rock-hard eye syndrome and its management.

Authors:  Oliver C F Lau; Jessica M Montfort; Benjamin W C Sim; Chris H L Lim; Tony S C Chen; Claire W Ruan; Ashish Agar; Ian C Francis
Journal:  J Cataract Refract Surg       Date:  2014-03-27       Impact factor: 3.351

2.  Complications of cataract surgery.

Authors:  M K Reddy
Journal:  Indian J Ophthalmol       Date:  1995-12       Impact factor: 1.848

3.  Malignant glaucoma. Clinical and ultrasound biomicroscopic features.

Authors:  G E Trope; C J Pavlin; A Bau; C R Baumal; F S Foster
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

4.  Pars-plana fluid aspiration for positive vitreous cavity pressure in anterior segment surgeries.

Authors:  Thomas Kuriakose; Smitha Jasper; Sherina Thomas
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848

  4 in total
  1 in total

1.  Response to comment on: Pars-plana fluid aspiration for positive vitreous cavity pressure in anterior segment surgeries.

Authors:  Thomas Kuriakose; Smitha Jasper; Sherina Thomas
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.